Member Info for MysticMike

I've watched Tim's interview a couple of times now and he does have a very poor memory for important things that interest shareholders.

1st point Tim the agreement with Avion was not a couple of years ago it was November 2018.

2nd point Tim your communications are getting worse because after each one you have to do an interview to clarify your previous communication.

3rd point Tim since being CEO the shareprice has dropped from 8.15 in July 21 to 2.10 now, and you are happy with what you have done. I hope you feel guilty about what has been lost on shareholders hard earned money, we believe in the drugs but not you as keep disappointing some of us.

My take away was Tim said at the beginning of the interview there were questions not answered by the RNS and guess what Tim failed yet again no detail or answers. Why we ask well the answer is Avion hold the purse strings and if they don't start spending the $25m soon it won't happen in H2. If they have to get a team together to run the trial most people in the positions they are looking to fill will have to give 3 months notice so after all the interview process they probably won't start until Sept/Oct at the earliest. Then the planning starts and the picking of patients etc for the trial. It does show a lack of confidence from both Imm and Avion that they were going to getapproval from the FDA. Wildtiger one question I would ask Tim would be for the salary he's being paid has he delivered for shareholders?

Come on Tim and Art you should be in a position now to tell us actual planned start date of the P2/P3 trial. Unless like previously they have just sat around waiting for the FDA feed back before they start planning and agreeing the start date and the number of people required for the trial. Very frustrating yet again with urgency of both Imm and Avion.

Below is a link to a recent Guardian Article

https://www.theguardian.com/world/2023/jun/18/georgians-dream-of-eu-membership-as-their-leaders-move-closer-to-putin

If Zenith are successful then they should pay a special dividend for all holders from yesterday's date.

Wild bunch it is not worth speaking to him he does not respond, as others have said fingers crossed for something just before the Lupuzor C meeting next week. I'm just frustrated like the rest of the shareholders who have been invested over 6 years.

Still no RNS telling us that they have submitted their IND application along with Orphan drug application. I would have thought they would had a draft ready and waiting as they felt so confident about the FDA meeting. Why is everything so slow with them or are there further changes required by the FDA that require a lot more work from Imm to able to submit the application? Come on Tim Mc tells what you are doing for your large salary.

Still no RNS telling us that they have submitted their IND application along with Orphan drug application. I would have thought they would had a draft ready and waiting as they felt so confident about the FDA meeting. Why is everything so slow with them or are there further changes required by the FDA that Imm have not shared?

Pokerchips, Tim'S been promising Sol partner for the last 2 years another broken promise or objective. He always talks the talk he reminds me of Arther Dalley.

The BOD need to pull their fingers out and get the Share price back up they have lost so much value down mainly to their poor running of the business. Please prove me wrong and pull a rabbit out of the hat.

Mick I would be ecstatic to get 100 frr shares to one BP share but at the moment I would be very happy to swap 1,000 frr shares for one BP.

All I would not get too excited just yet as we know from past experience the type C meeting will take place 16th May it will then take the FDA at least 2 months to respond and then it will take several weeks for Imm and Avion to review and tell us what was said. Then there will be another review required to send to the FDA an amended request which may need another type C meeting. What would be nice to told by Imm and Avion is when will the Lupuzor P2/P3 start in H2. You would hope that they are getting a list of patients for the start of the trial. Am I expecting too much? If they said the preparation time will take 3/4 months as we have to get the right people on the trial then at least we have the facts. I did hope to also what progress had been made by Avion using Imm as a Europe outlet. At this moment in time Imm are still my Hmm until we are well into H2.

Now the government have relaxed what you can pay into pensions in the last budget it will give people like Tim the green light to not retire and to take more out of businesses. It would be good to know if he is still on a reduced salary it should stay in place until the end of P2/P3trials which means he’s then actually delivered something other than stress and a massively reduced share price.

We should all hibernate like the Tim's and Avion we are only just getting to the end of Q1 and know that things will not start until H2. I would like to think that Imm and Avion are ready to start 1st July but we all know that it is going to be Q4.
The share price is sinking faster than Imm and Avion action by the end Q2 £0.75. We need an RNS detailing the agreed start dates.

I've been saying this for years about Tim McC if he can stretch things out he does. We are no further forward than in 2018/19 but Tim will say its not his fault plus he will say he is on a reduced wage now but what about all the years he robbed us Shareholders.

There is no prediction this week as both Tim's are resting due to a busy time in Q2 planning for the AGM and Avion have to write to FDA we still dont know if this has been or when it will be done. But I have a quick question about the Lupuzor update is H2 better than saying Q3 in the update or do we think it will be Q4 is the more likely start date due to Avion having to write again to the FDA and await response etc. I think even if the FDA said yes go ahead they would take their time.

Draye they said it will start in H2 not Q2 so it’s a long wait as that is what Tim does well.

MaverickD we won’t break 3.2 until Imm announce P2 has started or they give us the date. As we all know if they don’t tell us the detail they keep the SP from going down further. This share is a long long term investment.

Tim will have a very inactive week and be stress free due to his inactivity, the SP will drop initially possibly as low as 2.1 but it will rally on Thursday to 2.5 but back to 2.35 or lower on Friday. This time last year we had the excitement of the volunteers starting the increased dosing ready for P3 to start quickly after Q1, well P2 will not start until October/November and then P1 will be discussed with the FDA at the same time. Tim's slumber is only until later May when he needs to get ready for the AGM.

Come on Tim the market is telling you that your RNS's do not have enough detail in them, no wonder the SP has only moved downwards. Please please tell us more don't just tell your favoured shareholders we are all important and deserve to be treated properly. I personally believe you don't care enough please prove me wrong and tell us detail as it is now.